BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31892658)

  • 1. Standardising neonatal and paediatric antibiotic clinical trial design and conduct: the PENTA-ID network view.
    Folgori L; Lutsar I; Standing JF; Walker AS; Roilides E; Zaoutis TE; Jafri H; Giaquinto C; Turner MA; Sharland M
    BMJ Open; 2019 Dec; 9(12):e032592. PubMed ID: 31892658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonisation in study design and outcomes in paediatric antibiotic clinical trials: a systematic review.
    Folgori L; Bielicki J; Ruiz B; Turner MA; Bradley JS; Benjamin DK; Zaoutis TE; Lutsar I; Giaquinto C; Rossi P; Sharland M
    Lancet Infect Dis; 2016 Sep; 16(9):e178-e189. PubMed ID: 27375212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global shortage of neonatal and paediatric antibiotic trials: rapid review.
    Thompson G; Barker CI; Folgori L; Bielicki JA; Bradley JS; Lutsar I; Sharland M
    BMJ Open; 2017 Oct; 7(10):e016293. PubMed ID: 29030411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000-2016: A Systematic Review and Meta-Analysis.
    Pansa P; Hsia Y; Bielicki J; Lutsar I; Walker AS; Sharland M; Folgori L
    Drugs; 2018 Feb; 78(2):231-244. PubMed ID: 29218501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antibiotics for paediatric use: a review of a decade of regulatory trials submitted to the European Medicines Agency from 2000--why aren't we doing better?
    Garazzino S; Lutsar I; Bertaina C; Tovo PA; Sharland M
    Int J Antimicrob Agents; 2013 Aug; 42(2):99-118. PubMed ID: 23810180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
    Hwang TJ; Tomasi PA; Bourgeois FT
    PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process.
    Siapkara A; Fracasso C; Egger GF; Rizzari C; Trasorras CS; Athanasiou D; Turner MA;
    Arch Dis Child; 2021 Dec; 106(12):1149-1154. PubMed ID: 33858819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
    Pearson ADJ; Barry E; Mossé YP; Ligas F; Bird N; de Rojas T; Zimmerman ZF; Wilner K; Woessmann W; Weiner S; Weigel B; Venkatramani R; Valteau D; Trahair T; Smith M; Singh S; Selvaggi G; Scobie N; Schleiermacher G; Richardson N; Park J; Nysom K; Norga K; Merino M; McDonough J; Matloub Y; Marshall LV; Lowe E; Lesa G; Irwin M; Karres D; Gajjar A; Doz F; Fox E; DuBois SG; Donoghue M; Casanova M; Caron H; Buenger V; Bradford D; Blanc P; Barone A; Reaman G; Vassal G
    Eur J Cancer; 2021 Nov; 157():198-213. PubMed ID: 34536944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the European paediatric legislation in paediatric rheumatology: past, present and future.
    Ruperto N; Vesely R; Saint-Raymond A; Martini A;
    Ann Rheum Dis; 2013 Dec; 72(12):1893-6. PubMed ID: 23962457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-based antibiotic delivery for possible serious bacterial infections in neonates in low- and middle-income countries.
    Duby J; Lassi ZS; Bhutta ZA
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD007646. PubMed ID: 30970390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stop Antibiotics on guidance of Procalcitonin Study (SAPS): a randomised prospective multicenter investigator-initiated trial to analyse whether daily measurements of procalcitonin versus a standard-of-care approach can safely shorten antibiotic duration in intensive care unit patients--calculated sample size: 1816 patients.
    Assink-de Jong E; de Lange DW; van Oers JA; Nijsten MW; Twisk JW; Beishuizen A
    BMC Infect Dis; 2013 Apr; 13():178. PubMed ID: 23590389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Routine gastric residual volume measurement to guide enteral feeding in mechanically ventilated infants and children: the GASTRIC feasibility study.
    Tume LN; Woolfall K; Arch B; Roper L; Deja E; Jones AP; Latten L; Pathan N; Eccleson H; Hickey H; Parslow R; Preston J; Beissel A; Andrzejewska I; Gale C; Valla FV; Dorling J
    Health Technol Assess; 2020 May; 24(23):1-120. PubMed ID: 32458797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries.
    Hsia Y; Lee BR; Versporten A; Yang Y; Bielicki J; Jackson C; Newland J; Goossens H; Magrini N; Sharland M;
    Lancet Glob Health; 2019 Jul; 7(7):e861-e871. PubMed ID: 31200888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shortening the decade-long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low- and middle-income countries.
    Penazzato M; Lewis L; Watkins M; Prabhu V; Pascual F; Auton M; Kreft W; Morin S; Vicari M; Lee J; Jamieson D; Siberry GK
    J Int AIDS Soc; 2018 Feb; 21 Suppl 1(Suppl Suppl 1):. PubMed ID: 29485727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIHR Medicines for Children Research Network: improving children's health through clinical research.
    Rose AC; Van't Hoff W; Beresford MW; Tansey SP
    Expert Rev Clin Pharmacol; 2013 Sep; 6(5):581-7. PubMed ID: 24070097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in paediatric hospital antibiotic guidelines in Europe.
    Spyridis N; Syridou G; Goossens H; Versporten A; Kopsidas J; Kourlaba G; Bielicki J; Drapier N; Zaoutis T; Tsolia M; Sharland M;
    Arch Dis Child; 2016 Jan; 101(1):72-6. PubMed ID: 26416900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of the Belgian paediatric clinical trial network.
    Degraeuwe E; Persijn L; Nuytinck L; Allegaert K; De Taeye L; Gasthuys E; Christiaens D; Karamaria S; Raes A; Turner M; Vande Walle J
    Acta Clin Belg; 2024 Feb; 79(1):34-45. PubMed ID: 38054741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.